ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $105,000 | +425.0% | 15,641 | +851.4% | 0.00% | +300.0% |
| Q3 2021 | $20,000 | -87.5% | 1,644 | -78.3% | 0.00% | -80.0% |
| Q2 2021 | $160,000 | +321.1% | 7,577 | +413.7% | 0.01% | +150.0% |
| Q4 2020 | $38,000 | +137.5% | 1,475 | +250.4% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | -91.7% | 421 | -88.8% | 0.00% | -90.5% |
| Q2 2020 | $192,000 | +300.0% | 3,749 | +264.0% | 0.02% | +61.5% |
| Q2 2019 | $48,000 | -12.7% | 1,030 | -24.2% | 0.01% | -40.9% |
| Q1 2019 | $55,000 | +5400.0% | 1,359 | +6371.4% | 0.02% | – |
| Q3 2018 | $1,000 | -97.9% | 21 | -96.8% | 0.00% | -100.0% |
| Q1 2018 | $48,000 | – | 664 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |